|
1）McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimers disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimers Disease. Neurology. 1984; 34: 939-44
|
|
|
|
2）Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Neurology. 2001; 56: 1143-53
|
|
|
|
|
|
3）Jack CR Jr, Albert MS, Knopman DS, et al. Introduction to the recommendations from the National Institute on Aging-Alzheimers Asso-ciation workgroups on diagnostic guidelines for Alzheimers disease. Alzheimers Dement. 2011; 7: 257-62
|
|
|
|
|
|
4）McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimers disease: Recommendations from the National Institute on Aging-Alzheimers Association workgroups on diagnostic guidelines for Alzheimers disease. Alzheimers Dement. 2011; 7: 263-9
|
|
|
|
|
|
5）Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimers disease: recommendations from the National Institute on Aging-Alzheimers Asso-ciation workgroups on diagnostic guidelines for Alzheimers disease. Alzheimers Dement. 2011; 7: 270-9
|
|
|
|
|
|
6）Sperling RA, Aisen PS, Beckett LA, et al. Towards defining the preclinical stagse of Alzheimers disease: recommendations from the National Institute on Aging-Alzheimers Association workgroups on diagnostic guidelines for Alzheimers disease. Alzheimers Dement. 2011; 7: 280-92
|
|
|
|
|
|
7）Hampel H, Burger K, Teipel SJ, et al. Core candidate neurochemical and imaging biomarkers of Alzheimers disease. Alzheimers Dement. 2008; 4: 38-48
|
|
|
|
|
|
8）Jack Jr CR, Lowe VJ, Senjem ML, et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimers disease and amnestic mild cognitive impairment. Brain. 2008; 131: 665-80
|
|
|
|
|
|
9）Chetelat G, Villemagne VL, Bourgeat P, et al. Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Ann Neurol. 2010; 67: 317-24
|
|
|
|
|
|
10）McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimers disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimers Disease. Neurology. 1984; 34: 939-44
|
|
|
|
|
|
11）Burns A, Luthert P, Levy R, et al. Accuracy of clinical diagnosis of Alzheimers disease. BMJ. 1990; 301: 1026
|
|
|
|
|
|
12）Jack CR Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimers pathological cascade. Lancet Neurol. 2010; 9: 119-28
|
|
|
|
|
|
13）Fagan AM, Head D, Shah AR, et al. Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly. Ann Neurol. 2009; 65: 176-83
|
|
|
|
|
|
14）McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005; 65: 1863-72
|
|
|
|
|
|
15）Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology. 1993; 43: 250-60
|
|
|
|
|
|
16）Rascovsky K, Hodges JR, Kipps CM, et al. Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions. Alzheimer Dis Assoc Disord. 2007; 21: S14-8
|
|
|
|
|
|
17）Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998; 51: 1546-54
|
|
|
|
|
|
18）McKhann GM, Albert MS, Grossman M, et al. Clinical and pathological diagnosis of fronto-temporal dementia: report of the Work Group on Frontotemporal Dementia and Picks Disease. Arch Neurol. 2001; 58: 1803-9
|
|
|
|
|
|
19）Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011; 76: 1006-14
|
|
|
|
|
|
20）Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007; 6: 734-46
|
|
|
|
|
|
21）Alladi S, Xuereb J, Bak T, et al. Focal cortical presentations of Alzheimers disease. Brain. 2007; 130: 2636-45
|
|
|
|
|
|
22）Rabinovici GD, Jagust WJ, Furst AJ, et al. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol. 2008; 64: 388-401
|
|
|
|
|
|
23）Mayeux R, Saunders AM, Shea S, et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimers disease. Alzheimers Disease Centers Consortium on Apolipoprotein E and Alzheimers Disease. N Engl J Med. 1998; 338: 506-11
|
|
|
|
|
|
24）Schellenberg G. Early Alzheimers disease genetics. J Alzheimers Dis. 2006; 9: 367-72
|
|
|
|
|
|
25）Jack CR Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimers pathological cascade. Lancet Neurol. 2010; 9: 119-28
|
|
|
|
|
|
26）Reiman EM, Chen K, Alexander GE, et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimers dementia. Proc Natl Acad Sci U S A. 2004; 101: 284-9
|
|
|
|
|
|
27）Filippini N, MacIntosh BJ, Hough MG, et al. Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci U S A. 2003; 106: 7209-14
|
|
|
|
|
|
28）Sheline YI, Morris JC, Snyder AZ, et al. APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreaed CSF Abeta42. J Neurosci. 2010; 30: 17035-40
|
|
|
|
|
|
29）Vemuri P, Wiste HJ, Weigand SD, et al. Serial MRI and CSF biomarkers in normal aging, MCI, and AD. Neurology. 2010; 75: 143-51
|
|
|
|
|
|
30）Howieson DB, Carlson NE, Moore MM, et al. Trajectory of mild cognitive impairment onset. J Int Neuropsychol Soc. 2008; 14: 192-8
|
|
|
|
|
|
31）Shaw LM, Vanderstichele H, Knapik-Czajka M, et al. Cerebrospinal fluid biomarker signature in Alzheimers disease neuroimaging initiative subjects. Ann Neurol. 2009; 65: 403-13
|
|
|
|
|
|
32）Sperling RA, LaViolette PS, OKeefe K, et al. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron. 2009; 63: 178-88
|
|
|
|
|